Overview
Balance Sheet
Cash Flow
Growth Analysis
2023
2022
2021
2020
2019
Profitability Metrics
Gross Margin
149.66%
Operating Margin
64.72%
Net Margin
39.26%
Efficiency Metrics
Revenue per Expense Ratio
2.67
R&D as % of Revenue
0.00%
Earnings Quality
EBITDA Margin
0.00%
Income Tax Rate
21.54%
EPS
4.5100000000
Balance Sheet Analysis
Current Ratio
0.04
Cash Ratio
-0.03
Working Capital
$-13.30B
Debt to Equity
0.58
Debt to Assets
10.54%
Equity Ratio
18.34%
Cash Flow Analysis
Operating Cash Flow Ratio
61.09%
Free Cash Flow Ratio
57.89%
CapEx to Revenue
3.20%
Dividends Paid
$205.72M
Stock Buybacks
$72.25M
Total Shareholder Returns
$277.96M
Cash Position Change
8.08%
Key Takeaways (2023 FY)
Revenue declined by 4.1104572611016%, indicating potential market challenges
Increased dividend payments by 5.02%
Detailed Growth Metrics
Core Performance
Revenue
-4.11%
Net Income
-20.06%
EPS
-21.29%
Operating Income
-8.53%
Operational Efficiency
R&D Expenses
0.00%
SG&A Expenses
10.76%
Operating Cash Flow
27.61%
Free Cash Flow
31.91%
Balance Sheet Health
Assets
2.28%
Debt
101.35%
Book Value per Share
4.20%
Inventory
100.00%
Shareholder Returns
Dividends per Share
5.02%
Shares Outstanding
1.42%
Long Term Trends
3Y Revenue/Share
-4.68%
5Y Revenue/Share
10.33%
3Y Dividend/Share
18.55%
5Y Dividend/Share
48.58%